Kornitzer Capital Management Inc Jazz Pharmaceuticals PLC Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$122.5 - $147.16 $52,062 - $62,543	-425 Reduced 2.23%	18,600 $2.31 Million
Q2 2022 Aug 03, 2022	SELL	$141.59 - $168.66 $1,415 - $1,686	-10 Reduced 0.05%	19,025 $2.97 Million
Q1 2022 Apr 27, 2022	SELL	$129.64 - $160.7 $772,006 - $956,968	-5,955 Reduced 23.83%	19,035 $2.96 Million
Q4 2021 Feb 01, 2022	SELL	$119.87 - $145.67 $10,188 - $12,381	-85 Reduced 0.34%	24,990 $3.18 Million
Q3 2021 Nov 03, 2021	SELL	$128.64 - $184.79 $186,527 - $267,945	-1,450 Reduced 5.47%	25,075 $3.27 Million
Q2 2021 Jul 30, 2021	BUY	$160.2 - $186.42 $1.19 Million - $1.38 Million	7,425 Added 38.87%	26,525 $4.71 Million
Q1 2021 Apr 30, 2021	BUY	$150.19 - $173.5 $75,095 - $86,750	500 Added 2.69%	19,100 $3.14 Million
Q4 2020 Jan 29, 2021	BUY	$140.71 - $165.05 $2.62 Million - $3.07 Million	18,600 New	18,600 $3.07 Million
Q2 2020 Aug 03, 2020	SELL	$95.68 - $121.88 $507,486 - $646,451	-5,304 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$87.74 - $152.74 $304,984 - $530,924	-3,476 Reduced 39.59%	5,304 $529,000
Q4 2019 Jan 31, 2020	SELL	$117.65 - $153.73 $962,377 - $1.26 Million	-8,180 Reduced 48.23%	8,780 $1.31 Million
Q3 2019 Nov 04, 2019	SELL	$125.18 - $143.24 $2.28 Million - $2.61 Million	-18,195 Reduced 51.76%	16,960 $2.17 Million
Q2 2019 Jul 31, 2019	BUY	$125.55 - $144.48 $2.23 Million - $2.57 Million	17,777 Added 102.3%	35,155 $5.01 Million
Q4 2018 Jan 31, 2019	BUY	$115.94 - $166.74 $9,854 - $14,172	85 Added 0.49%	17,378 $2.15 Million
Q2 2018 Aug 02, 2018	BUY	$146.33 - $183.18 $2.53 Million - $3.17 Million	17,293 New	17,293 $2.98 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account